Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

Training for Organoids modelling Physiology and Pathology in the human gastrointestinal tract

Project description

Training on patient-derived organoids in the gastrointestinal tract

As society ages, degenerative diseases and cancer rates are rising, while drug development faces high failure rates. Advances in stem cell biology and microfluidics have led to the creation of new human organ models that could replace animal testing and support precision medicine. Supported by the Marie Skłodowska-Curie Actions programme, the TOP-GUT project focuses on advanced gastrointestinal (GI) tract models. The GI tract is highly relevant as a major site of cancer development, inflammation, and drug absorption. This initiative seeks to enhance existing GI models and develop more complex systems based on patient-derived organoids and organ-on-chip devices to promote their use in personalized medicine. The project will provide training for researchers on patient-derived model development, as well as on the ethical and legal challenges involved in their implementation.

Objective

In the aging society, disease burden, such as degenerative diseases and cancer are rising while drug development successes are limited, due to high drug failure rates in the transition from animal experimentation to human patients. This demands re-thinking of the currently used models. Advances in stem cell biology and microfluidics have created new human organ models. These models are neither fully understood, nor fully mimicking the complexity of the tissue. With this new ability to build human stem cell-based models, we have a responsibility to drive these models to implementation – aiming to replace animal experimentation and provide next generation patient avatars for precision medicine.
TOP-GUT combines cutting-edge basic and translational science with an outstanding program of education to unleash the full potential of new human organ models, specifically patient-derived organoids and organ-on-chip devices. TOP-GUT will focus on the gastrointestinal (GI) tract, which is the bodies second largest interface with the environment. It is medically highly relevant not only as a major site of cancer development, as target of infectious agents, and as site of inflammatory diseases, but also as one of the major organs for drug uptake and relevance in toxicology. TOP-GUT aims to significantly contribute to our understanding of the current GI models, establish new tools and protocols for more complex GI models, and advance the use of GI models for personalised medicine. In addition, TOP-GUT will address ethical and legal issues to foster acceptance and implementation of the GI models. TOP-GUT will build a solid European network to cooperate, standardize and push GI models into applications, bringing together academia and industry. Together, TOP-GUT educates the next generation of researchers to become new leaders in the field and to drive the implementation of new stem cell based human models to replace animal experimentation in academia and industry.

Fields of science (EuroSciVoc)

Keywords

Programme(s)

Topic(s)

Funding Scheme

HORIZON-TMA-MSCA-DN - HORIZON TMA MSCA Doctoral Networks

See all projects funded under this funding scheme

Call for proposal

(opens in new window) HORIZON-MSCA-2022-DN-01

See all projects funded under this call

Coordinator

TECHNISCHE UNIVERSITAT BERLIN
Net EU contribution
€ 260 539,20
Address
STRASSE DES 17 JUNI 135
10623 Berlin
Germany
Region
Berlin Berlin Berlin
Activity type
Higher or Secondary Education Establishments
Links
Total cost
No data

Participants (7)

Partners (15)